SRZN Latest Press Releases

-- October 20, 2026 --

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million Globe Newswire 4:59 PM

-- October 2, 2026 --

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema Globe Newswire 8:00 AM

-- September 8, 2026 --

Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema Globe Newswire 8:30 AM

-- September 2, 2026 --

Surrozen to Present at Upcoming Healthcare Investor Conferences Globe Newswire 4:05 PM

-- August 6, 2026 --

Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- July 15, 2026 --

Surrozen to Present at Upcoming Healthcare Investor Conference Globe Newswire 4:05 PM

Market Data Delayed 15 Minutes